Status:
COMPLETED
Behavioral Activation for Opioid Use Disorder
Lead Sponsor:
University of Minnesota
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall purpose of this pilot study is to evaluate the feasibility and acceptability of values-based behavioral activation (BA) as an adjunct intervention for patients receiving medications for op...
Eligibility Criteria
Inclusion
- At least 18 years of age.
- Diagnosis of opioid use disorder.
- Have an active prescription for buprenorphine-naloxone (Suboxone) for at least one month.
- Patient at Broadway Family Medicine (BFM)
Exclusion
- Concurrent individual psychotherapy with a psychologist or counselor at least monthly
- Active suicidal ideation (intention, plan, or attempt in the past 30 days, as determined by chart review)
- Dementia, developmental disabilities, or cognitive functioning that is too low to participate in therapy, as determined by chart review
Key Trial Info
Start Date :
March 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2023
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05262725
Start Date
March 30 2022
End Date
February 23 2023
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455